Are TNF inhibitors still the agent of choice for RA?

被引：0
|
作者：
Taylor, Peter C. [1 ]
机构：
[1] Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskeleta, Oxford, England
来源：
NATURE REVIEWS RHEUMATOLOGY | 2023年
关键词：
RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; METHOTREXATE; COMBINATION; ADALIMUMAB;
D O I：
10.1038/s41584-023-01043
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Since entering the clinic 25 years ago, biologic TNF inhibitors have transformed the outlook for people with rheumatoid arthritis and set the standard for all other targeted therapies. Despite changes to the therapeutic landscape, TNF inhibitors look set to remain an important treatment option for the foreseeable future.
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapy
    Amstad, Andrea
    Papagiannoulis, Eleftherios
    Scherer, Almut
    Rubbert-Roth, Andrea
    Finckh, Axel
    Mueller, Ruediger
    Dudler, Jean
    Moeller, Burkhard
    Villiger, Peter M.
    Schulz, Martin M. P.
    Kyburz, Diego
    RHEUMATOLOGY, 2022, 62 (01) : 89 - 97
  • [22] Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?
    Saleem, Benazir
    Keen, Helen
    Goeb, Vincent
    Parmar, Rekha
    Nizam, Sharmin
    Hensor, Elizabeth M. A.
    Churchman, Sarah M.
    Quinn, Mark
    Wakefield, Richard
    Conaghan, Philip G.
    Ponchel, Frederique
    Emery, Paul
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (09) : 1636 - 1642
  • [23] Janus kinase inhibitors clear to land Janus kinase inhibitors in RA
    Aringer, Martin
    RHEUMATOLOGY, 2018, 57 (07) : 1131 - 1132
  • [24] TNF-α and its inhibitors in cancer
    Zidi, Ines
    Mestiri, Souhir
    Bartegi, Aghleb
    Ben Amor, Nidhal
    MEDICAL ONCOLOGY, 2010, 27 (02) : 185 - 198
  • [25] The Comparative Safety of TNF Inhibitors in Ankylosing Spondylitis-a Meta-Analysis Update of 14 Randomized Controlled Trials
    Hou, Li-qiong
    Jiang, Ga-xue
    Chen, Yan-fei
    Yang, Xi-Mei
    Meng, Lei
    Xue, Miao
    Liu, Xiao-guang
    Chen, Xi-chao
    Li, Xiao
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2018, 54 (02) : 234 - 243
  • [26] Pharmacodynamics OF TNF α inhibitors for the treatment of psoriasis
    Campanati, Anna
    Paolinelli, Matteo
    Diotallevi, Frederico
    Martina, Emanuela
    Molinelli, Elisa
    Offidani, Annamaria
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (11) : 913 - 925
  • [27] Methotrexate Reduces the Probability of Discontinuation of TNF Inhibitors in Seropositive Patients With Rheumatoid Arthritis. A Real-World Data Analysis
    Hernandez-Breijo, Borja
    Brenis, Claudia M.
    Plasencia-Rodriguez, Chamaida
    Martinez-Feito, Ana
    Novella-Navarro, Marta
    Pascual-Salcedo, Dora
    Balsa, Alejandro
    FRONTIERS IN MEDICINE, 2021, 8
  • [28] Start RA treatment - Biologics or JAK-inhibitors?
    Caporali, Roberto
    Germinario, Sabino
    Kacsandi, Dorottya
    Choy, Ernest
    Szekanecz, Zoltan
    AUTOIMMUNITY REVIEWS, 2024, 23 (01)
  • [29] TNF inhibitors in rheumatoid arthritis and spondyloarthritis: Are they the same?
    Rubbert-Roth, Andrea
    Atzeni, Fabiola
    Masala, Ignazio Francesco
    Caporali, Roberto
    Montecucco, Carlomaurizio
    Sarzi-Puttini, Piercarlo
    AUTOIMMUNITY REVIEWS, 2018, 17 (01) : 24 - 28
  • [30] TNF-alpha inhibitors: Current indications
    Sharma, Rashmi
    Sharma, Charnan Lal
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2007, 11 (03) : 139 - 148
12345